Rational Design of a Potent, Long-Lasting Form of Interferon: A 40 kDa Branched Polyethylene Glycol-Conjugated Interferon α-2a for the Treatment of Hepatitis C

Citations Over TimeTop 10% of 2001 papers

Abstract

A potent, long-lasting form of interferon alpha-2a mono-pegylated with a 40 kilodalton branched poly(ethylene glycol) was designed, synthesized, and characterized. Mono-pegylated interferon alpha-2a was comprised of four major positional isomers involving Lys31, Lys121, Lys131, and Lys134 of interferon. The in vitro anti-viral activity of pegylated interferon alpha-2a was found to be only 7% of the original activity. In contrast, the in vivo antitumor activity was severalfold enhanced compared to interferon alpha-2a. Pegylated interferon alpha-2a showed no immunogenicity in mice. After subcutaneous injection of pegylated interferon alpha-2a, a 70-fold increase in serum half-life and a 50-fold increase in mean plasma residence time concomitant with sustained serum concentrations were observed relative to interferon alpha-2a. These preclinical results suggest a significantly enhanced human pharmacological profile for pegylated interferon alpha-2a. Results of Phase II/III hepatitis C clinical trials in humans confirmed the superior efficacy of pegylated interferon alpha-2a compared to unmodified interferon alpha-2a.

Related Papers

• → Pegylation and Its Impact on the Design of New Protein-Based Medicines(2014)89 cited
• → Photocleavable Polyethylene Glycol for the Light-Regulation of Protein Function(2010)50 cited
• → The impact of PEGylation on protein immunogenicity(2013)50 cited
• → Determination of PEGylation homogeneity of polyethylene glycol‐modified canine uricase(2020)2 cited
• Phase-separation property of polyethylene glycol (PEG) or IgG conjugated PEG with dextran in microchannel(2007)